- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
TransMedics Group Inc (TMDX)
TransMedics Group Inc stock price live, this page displays NASDAQ TMDX stock exchange data. View the TMDX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the TransMedics Group Inc real time stock price chart below.
What Is the TransMedics Group Inc Stock Price Today?
The TransMedics Group Inc stock price today is 87.05.
What Is the Stock Symbol for TransMedics Group Inc?
The stock symbol for TransMedics Group Inc is "TMDX."
What Stock Exchange Does TransMedics Group Inc Trade On?
TransMedics Group Inc is listed and trades on the NASDAQ stock exchange.
Is TransMedics Group Inc a Good Stock to Buy?
Determining whether TransMedics Group Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TMDX quote. (ISIN: US89377M1099)
What Is the TransMedics Group Inc Stock Price Today?
The TransMedics Group Inc stock price today is 87.05.
What Is the Stock Symbol for TransMedics Group Inc?
The stock symbol for TransMedics Group Inc is "TMDX."
What Stock Exchange Does TransMedics Group Inc Trade On?
TransMedics Group Inc is listed and trades on the NASDAQ stock exchange.
Is TransMedics Group Inc a Good Stock to Buy?
Determining whether TransMedics Group Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TMDX quote. (ISIN: US89377M1099)
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
86.12
88.15
52 wk Range
60.11
156.00
TMDX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
86.1288.15
52 wk Range
60.11156.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TMDX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
97.30
Upside
+11.77%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Analyst Ratings
8 Buy
4 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 97.30
(+11.77% Upside)
TransMedics Group Inc SWOT Analysis
Organ Tech Pionee | TransMedics leads organ transplant innovation with its Organ Care System, revolutionizing preservation and transport of donor organs |
Financial Health | Strong revenue growth and ambitious targets highlight TransMedics' potential, with 2024 guidance projecting up to 79% year-over-year increase |
Market Expansion | TransMedics aims for 10,000 transplants by 2028, targeting $1.2 billion in revenue through new product lines and international growth |
Analyst Outlook | Price targets range from $90 to $110, reflecting confidence in TransMedics' growth potential despite recent CFO transition and market challenges |
TransMedics Group Inc Earnings Call Summary for Q2/2026
- Q2 revenue hit record $190M, up 21% YoY, beating estimates by 3.4%; adjusted EPS of $0.44 missed forecast of $0.5255 by 16.3%
- Stock fell 4.35% to $78 after-hours as investors reacted to earnings miss and reduced operating margin guidance to 12.5%-14% from 16%
- TransMedics raised FY2026 revenue guidance to $737M-$757M, implying 22%-25% growth; logistics revenue surged 39% YoY to $41M
- Lower margin outlook reflects increased investment in OCS Kidney program and strategic initiatives; PAD Aviation consolidation expected to be dilutive
- CEO targets 30,000 transplants by 2032 generating $2B+ annual revenue; emphasized vertical integration as key competitive differentiator
Last Updated: 2026-08-04, 06:06 p/m
Read Full TranscriptEarnings
Latest Release
Aug 04, 2026
EPS / Forecast
0.44 / 0.53
Revenue / Forecast
189.95M / 183.78M
Compare TMDX to Peers and Sector
Metrics to compare | TMDX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTMDXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 19.9x | 10.7x | −0.4x | |
PEG Ratio | 0.21 | −0.10 | 0.00 | |
Price/Book | 5.8x | 2.3x | 2.6x | |
Price / LTM Sales | 4.5x | 2.5x | 3.1x | |
Upside (Analyst Target) | 9.1% | 116.7% | 47.5% | |
Fair Value Upside | Unlock | 24.6% | 5.9% | Unlock |
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the TransMedics (TMDX) Stock Price Today?
The TransMedics stock price today is 87.05 USD.
What Stock Exchange Does TransMedics Trade On?
TransMedics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for TransMedics?
The stock symbol for TransMedics is "TMDX."
What Is the TransMedics Market Cap?
As of today, TransMedics market cap is 3.03B USD.
What Is TransMedics's Earnings Per Share (TTM)?
The TransMedics EPS (TTM) is 4.01.
When Is the Next TransMedics Earnings Date?
TransMedics will release its next earnings report on Nov 04, 2026.
From a Technical Analysis Perspective, Is TMDX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has TransMedics Stock Split?
TransMedics has split 0 times.
How Many Employees Does TransMedics Have?
TransMedics has 898 employees.
What is the current trading status of TransMedics (TMDX)?
As of Aug 12, 2026, TransMedics (TMDX) is trading at a price of 87.05 USD, with a previous close of 89.36 USD. The stock has fluctuated within a day range of 86.12 USD to 88.15 USD, while its 52-week range spans from 60.11 USD to 156.00 USD.
What Is TransMedics (TMDX) Price Target According to Analysts?
The average 12-month price target for TransMedics is 97.30 USD, with a high estimate of 125 USD and a low estimate of 65 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +11.77% Upside potential.
What Is the TMDX Premarket Price?
TMDX's last pre-market stock price is 88.00 USD. The pre-market share volume is 4,730.00, and the stock has decreased by -1.36, or -1.52%.
What Is the TMDX After Hours Price?
TMDX's last after hours stock price is 87.03 USD, the stock has decreased by 0.01, or 0.01%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.